Summary

A new study published in JAMA Network Open on May 7, 2026, engaged 42 national experts in hospital-based addiction treatment in a consensus-building process to develop best practices for hospital-initiated medications for opioid use disorder (MOUD). Hospitalization offers a critical opportunity for individuals with opioid use disorder (OUD) to begin treatment with evidence-based medications, such as buprenorphine and methadone. However, clinicians have faced challenges initiating treatment with these medications in patients who are using fentanyl and other high-potency synthetic opioids (HPSOs).

AI summaries can be wrong sometimes—always verify important details using the source article.